Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice

Journal of Hepatology

Volumn 49, Issue 5, 2008, Pages 779-786

  Tatsumi, Tomohide ^a,b,c   Takehara, Tetsuo ^a,c   Yamaguchi, Shinjiro ^a,c   Sasakawa, Akira ^a,c   Yamamoto, Masashi ^a,c   Fujita, Yui ^a   Miyagi, Takuya ^a   Ohkawa, Kazuyoshi ^a   Hayashi, Norio ^a,c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Galactosylceramide; Antitumor immunity; CD1d; Liver dendritic cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; INNATE IMMUNITY; LIVER CELL; LIVER METASTASIS; LIVER TUMOR; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD1D; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; GALACTOSYLCERAMIDES; IMMUNITY, INNATE; IMMUNOTHERAPY; KILLER CELLS, NATURAL; LIVER NEOPLASMS, EXPERIMENTAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NATURAL KILLER T-CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR BURDEN;

EID: 53249111360     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.06.011     Document Type: Article

References (23)

1. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., et al. CD1d-restricted and TCR-mediated activation of Vα14NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
2. Fujii S., Shimizu K., Kronenberg M., and Steinman R.M. Prolonged IFN-γ- producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol 3 (2002) 867-874
3. Gonzalez-Aseguinolaza G., de Oliveira C., Tomaska M., Hong S., Bruna-Romero O., Nakayama T., et al. α-Galactosylceramide-activated Vα 14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci USA 97 (2000) 8461-8466
4. Miyagi T., Takehara T., Tatsumi T., Kanto T., Suzuki T., Jinushi M., et al. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver. Int J Cancer 106 (2003) 81-89
5. Nakagawa R., Motoki K., Ueno H., Iijima R., Nakamura H., Kobayashi E., et al. Treatment of hepatic metastasis of the colon26 adenocacinoma with an α-galactosylceramide, KRN7000. Cancer Res 58 (1998) 1202-1207
6. Nieda M., Okai M., Tazbirkova A., Lin H., Yamaura A., Ide K., et al. Therapeutic activation of Vα24 + Vβ11 + NKT cells in human subjects results in highly coordinates secondary activation of acquired and innate immunity. Blood 103 (2004) 383-389
7. Giaccone G., Punt C.J., Ando Y., Ruijter R., Nishi N., Peters M., et al. A phase I study of the natural killer T-cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 8 (2002) 3702-3709
8. Tatsumi T., Takehara T., Yamaguchi S., Sasakawa A., Sakamori R., Ohkawa K., et al. Intrahepatic delivery of α-galatosylceramide pulsed dendritic cells suppresses liver tumor. Hepatology 45 (2007) 22-30
9. Takehara T., Uemura A., Tatsumi T., Suzuki T., Kimura R., Shiotani A., et al. Natural killer cell-mediated ablation of metastatic liver tumors by hydrodynamic injection of IFN alpha gene to mice. Int J Cancer 120 (2007) 1252-1260
10. Ronger-Savle S., Valladeau J., Claudy A., Schmitt D., Pequet-Navarro J., Dezutter-Dambuyant C., et al. TGFbeta inhibits CD1d expression on dendritic cells. J Invest Dermatol 124 (2005) 116-118
11. Gerlini G., Tun-Kyi A., Dudli C., Burg G., Pimpinelli N., and Nestle F.O. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol 165 (2004) 1853-1863
12. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5 (1999) 405-411
13. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., and Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195 (2002) 327-333
14. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., and Munz C. Human dendritic cells activate resting NK cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195 (2002) 343-351
15. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14NKT cells. Proc Natl Acad Sci USA 95 (1998) 5690-5693
16. Kitamura H., Iwakabe K., Yahata T., Nishimura S., Ohta S., Ohmi Y., et al. The natural killer T (NKT) cell ligandα-galactosylceramide demonstrates its immunopoteniating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189 (1999) 1121-1128
17. Ferlazzo G., and Munz C. NK cell compartments and their activation by dendritic cells. J Immunol 172 (2004) 1333-1339
18. Seino K., Motohashi S., Fujisawa T., Nakayama T., and Taniguchi M. Natural killer T cell-mediated antitumor immune responses and their clinical applications. Cancer Sci 97 (2006) 807-812
19. Osman Y., Kawamura T., Naito T., Takeda K., Van Kaer L., Okumura K., et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur J Immunol 30 (2000) 1919-1928
20. Doherty D.G., and O'Farrelly C. Innate and adaptive lymphoid cells in human liver. Immunol Rev 174 (2000) 5-20
21. Mehal W.Z., Azzaroli F., and Crispe I.N. Immunology of the healthy liver: old questions and new insights. Gatsroenterology 120 (2001) 250-260
22. Biswas S., Guix M., Rinehart C., Dugger T.C., Chytil A., Moses H.L., et al. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest 117 (2007) 1305-1313
23. de Lalla C., Galli G., Aldrighhetti L., Romeo R., Mariani M., Monno A., et al. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 173 (2004) 1417-1425